Cultured lymphoblastoid cell lines (LBLs) derived from MGS patients with mutations in ORC1, ORC4, ORC6, CDT1 and CDC6 grow efficiently demonstrating that the mutations do not fully abrogate origin licensing, which is essential for cell growth (the mutations in these cell lines are described in Table S1). The gene discussed is ORC6; the disease is Mungan syndrome.